United States: The New Study reveals that the three time ultrasounds done in the early weeks of the pregnancy in the Woman cannot show signs of brain damage in the foetus, however, it was later diagnosed with the birth defect microcephaly, as per the researchers.
The scientists from the United States, found that the Woman whom such experiment was effected was Finnish one living in United States and was notably, infected by ‘Zika virus’. Even after three ultrasounds which were done in the early weeks of the pregnancy, the researchers could not see any damage in the foetus.
The concerned woman was not identified, however, it was made clear that she was infected by the Zika Virus while travelling on vacation in Mexico, Guatemala and Belize in last year (November). However, researchers could not found the exact location of transmission.
The followed up study where magnetic resonance imaging or MRI found showing the extensive brain defects. Moreover, as per scientists, the brain in foetus found shrunken from a normal head circumference I the 47th percentile, while there being a Sixteenth wee to the 24th percentile in Twentieth week. Even as it was, the researchers found reportedly, not a still small head circumference for classifying as microcephaly.
However, it was seen that the woman so taken for the study, considering the extent of the damages which was seen through MRI, decided to terminate her pregnancy while in 21st week thereof.
Thus, the study paper found suggesting that the doctors now should take care and caution while reassuring the patients who have normal foetus, while there being ultrasound examinations as early to the pregnancies. The statements were preferred by the Director of the Fetal Medicine Institute at Children’s National Health System in Washington, DC- Adre du Plessis, who is also the co- author of the study.
Moreover, while terming the situation “very bad”, Du Plessis suggest to know this for sure that “if the fetal brain is affected”.
The study has been published yesterday, i.e. on Wednesday 30th March, in the ‘New England Journal of Medicine’.
